A big congratulations to INFANT Lead Investigator Mark O ‘Sullivan on his recent success in qualifying as a finalist at the Parkview Health and MATTER 2022 Healthy Mom and Baby 3.0 Innovation Competition with the Neurobell project.
Neurobell is an Enterprise Ireland-funded commercialization project and team from the INFANT Research Centre at University College Cork. Neurobell is developing a novel medical device for early detection and monitoring of seizures in newborns. Their pocket-sized and wireless EEG monitor provides bedside staff with easy-to-use EEG and automated alerts for seizures in real time.
Launched in May 2022, the Parkview Health and MATTER 2022 Healthy Mom and Baby 3.0 Innovation Competition challenges innovators to submit innovative solutions to help improve access to care and management of chronic conditions for mothers, infants and children.
The four finalists will participate in a two-month virtual accelerator where they will continue to build and test their solutions with leaders from Parkview Health, MATTER and Management Performance Hub. On November 10, 2022, the finalists will pitch their solutions to a community of healthcare professionals, Parkview leaders and outside investors for potential pilot and funding opportunities. All teams who participate in the final pitch day will receive a six-month global membership at MATTER.
Best of luck in the final Mark!!
